ABT (Abbott Laboratories) Other Operating Expense: $1,684 Mil (TTM As of Mar. 2026)


ABT Abbott Laboratories ABT
76 GF Score
Price $95.84
GF Value $130.18
Valuation Modestly Undervalued
View Full Analysis

What is Abbott Laboratories Other Operating Expense?

Abbott Laboratories ABT +0.22% 76 Other Operating Expense is $1,684 Mil as of Mar. 2026. GuruFocus rates ABT with a GF Score™ of 76/100 and a GF Value™ of $130.18 (Modestly Undervalued).

Abbott Laboratories's Other Operating Expense for the three months ended in Mar. 2026 was $422 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $1,684 Mil.

Abbott Laboratories's quarterly Other Operating Expense increased from Sep. 2025 ($420 Mil) to Dec. 2025 ($422 Mil) but then stayed the same from Dec. 2025 ($422 Mil) to Mar. 2026 ($422 Mil).

Abbott Laboratories's annual Other Operating Expense declined from Dec. 2023 ($1,966 Mil) to Dec. 2024 ($1,878 Mil) and declined from Dec. 2024 ($1,878 Mil) to Dec. 2025 ($1,682 Mil).

Abbott Laboratories Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Other Operating Expense Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,047.00 2,013.00 1,966.00 1,878.00 1,682.00

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 420.00 420.00 420.00 422.00 422.00
ABT
76GF Score
Abbott Laboratories ABT
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,684 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $1,684 Mil mean?
Abbott Laboratories (ABT) has a Other Operating Expense of $1,684 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Other Operating Expense too high?
Abbott Laboratories' current Other Operating Expense is $1,684 Mil. Overall, Abbott Laboratories has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Other Operating Expense compare to SYK and MDT?
Abbott Laboratories' Other Operating Expense of $1,684 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Other Operating Expense is $1,684 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Modestly Undervalued. The stock's GF Value™ is $130.18, compared to a current price of $95.84 — trading 26.4% below its estimated fair value. The current Other Operating Expense is $1,684 Mil. Abbott Laboratories' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current Other Operating Expense is $1,684 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of $95.84 is trading 26.4% below its estimated GF Value™ of $130.18. GuruFocus considers Abbott Laboratories to be Modestly Undervalued.

Key valuation signals for ABT:

  • Other Operating Expense: $1,684 Mil
  • GF Value™: $130.18 vs. price of $95.84 (26.4% below fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
76GF Score

Get the complete analysis for ABT

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$95.84
Price
$130.18
GF Value